In response to 'do pharmacotherapy and/or psychotherapy work in depression? it depends!' and 'widespread methodological problems limit validity of meta-analytic results'

Psychotherapy and Psychosomatics

Volumn 80, Issue 4, 2011, Pages 247-248

  Pigott, H Edmund ^a,b   Alter, Gregory S ^a  

^a NeuroAdvantage   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM; ESCITALOPRAM; PLACEBO; SEROTONIN UPTAKE INHIBITOR;

DEPRESSION; DRUG TOLERABILITY; HEALTH PROGRAM; HUMAN; INSOMNIA; LETTER; MAJOR DEPRESSION; MEDICAL INFORMATION; META ANALYSIS (TOPIC); METHODOLOGY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PSYCHOTHERAPY; PUBLICATION; RISK ASSESSMENT;

EID: 79955458634     PISSN: 00333190     EISSN: 14230348     Source Type: Journal    
DOI: 10.1159/000323614     Document Type: Letter

References (21)

1. Hoyer J, Höfler M: Do pharmacotherapy and/or psychotherapy work in depression? It depends! Psychother Psychosom 2011;80:245.
2. Huf W, Kalcher K, Kasper S: Widespread methodological problems limit validity of meta-analytic results. Psychother Psychosom 2011;80:246.
3. Pigott HE, Leventhal AM, Alter GS, Boren JJ: Efficacy and effectiveness of antidepressants: current status of research. Psychother Psychosom 2010; 79: 267-279.
4. Turner EH, Matthews AM, Linardatos, E, Tell RA, Rosenthal R: Selective publication of antidepressant trials and its influence on apparent efficacy. N Engl J Med 2008; 358: 252-260.
5. Kirsch I, Moore T, Scoboria A, Nicholls S: The emperor's new drugs: an analysis of antidepressant medication data submitted to the US Food and Drug Administration. Prevent Treat 2002; 5:article 23.
6. Kirsch I, Deacon B, Huedo-Medina TB, Moore TJ, Johnson BT: Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration. PLoS Med 2008; 5:e45.
7. Barbui C, Furukawa TA, Cipriani A: Effectiveness of paroxetine in the treatment of acute major depression in adults: a systematic re-examination of published and unpublished data from randomized trials. Can Med Ass J 2008; 178: 296-305. (Pubitemid 351212875)
8. Eyding D, Lelgemann M, Grouven U, Härter M, Kromp M, Kaiser T, Kerekes MF, Gerken M, Wieseler B: Reboxetine for acute treatment of major depression: systematic review and meta-analysis of published and unpublished placebo and selective serotonin reuptake inhibitor controlled trials. BMJ 2010; 341:c4737.
9. Practice guideline for the treatment of patients with major depressive disorder, ed 2. American Psychiatric Association Press, 2000.
10. Rush AJ, Fava M, Wisniewski SR, Lavori PW, Trivedi MH, Sackeim HA, Thase ME, Nierenberg AA, Quitkin FM, Kashner TM, Kupfer DJ, Rosenbaum JF, Alpert J, Stewart JW, McGrath PJ, Biggs MM, Shores- Wilson K, Lebowitz BD, Ritz L, Niederehe G: Sequenced treatment alternatives to relieve depression (STAR * D): rationale and design. Control Clin Trials 2004; 25: 119-142. (Pubitemid 38230109)
11. Pigott HE: STAR * D: a tale and trail of bias. Ethical Hum Psychol Psychiatry, in press.
12. NIMH: Sequenced Treatment Alternatives to Relieve Depression (STAR * D) contract protocol. 2002 (obtained through the Freedom of Information Act, October 1, 2010).
13. Rush AJ: STAR * D: what have we learned? Am J Psychiatry 2007; 164: 201-204. (Pubitemid 46318553)
14. NIMH: Sequenced Treatment Alternatives to Relieve Depression (STAR * D): publications. 2009. http://www.clinicaltrials.gov/ct/show/ NCT00021528?order=1 (accessed December 3, 2010).
15. Sunderajan P, Gaynes BN, Wisniewski SR, Miyahara S, Fava M, Akingbala F, DeVeaugh-Geiss J, Rush AJ, Trivedi MH: Insomnia in patients with depression: a STAR * D report. CNS Spectr 2010; 15: 394-404.
16. Rush AJ, Trivedi MH, Wisniewski SR, Stewart JW, Nierenberg AA, Thase ME, Ritz L, Biggs MM, Warden D, Luther JF, Shores-Wilson K, Niederehe G, Fava M: Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression. N Engl J Med 2006; 354: 1231-1242.
17. Pigott HE: Freedom of information act request for all data analytic reports provided by STAR * D's investigators to NIMH as specified contract N01 MH-90003 (October 14, 2010).
18. Pigott HE: Notes of conference call with George Niederehe, government program officer responsible for STAR * D, Stephen Wisniewski, STAR * D chief biostatistician, and Lisa Alberts, NIMH Freedom of Information Coordinator (December 3, 2010).
19. NIMH: Available limited access datasets from NIMH clinical trials: Sequenced Treatment Alternatives to Relieve Depression (STAR * D). http://www.nimh.nih.gov/trials/datasets/nimh-procedures-for-requesting- data-sets.shtml (accessed December 3, 2010).
20. Papakostas GI, Nelson JC, Kasper S, Möller HJ: A meta-analysis of clinical trials comparing reboxetine, a norepinephrine reuptake inhibitor, with selective serotonin reuptake inhibitors for the treatment of major depressive disorder. Eur Neuropsychopharmacol 2008; 18: 122-127. (Pubitemid 350296847)
21. Montgomery S, Hansen T, Kasper S: Efficacy of escitalopram compared to citalopram: a meta-analysis. Int J Neuropsychopharmacol 2010: 1-8.